Overall baseline characteristics: median age 62 years, 25.6% female, 87.6% white, 90% high intensity statin use, mean LDL-C 70.3 and HDL-C 33.3 mg/dl, median HbA1c 7.3%, and 11% with CKD. In patients with CKD, expanded MACE occurred in 12.9% on APB and 25% on PBO (HR 0.48, 95% CI 0.26-0.89 (p=0.02). In patients without CKD, expanded MACE occurred in 11.3% and 12.7% with APB or PBO, respectively (HR 0.89, 95% CI 0.70-1.14 (p=0.38).  The interaction of CKD and treatment on expanded MACE was significant (P=0.03). (Bolding added)